NCT05359952

Brief Summary

The central goal of this randomized, controlled pilot study is to examine the feasibility, acceptability, and preliminary effects of an educational intervention (called "Starting the Conversation"; STC) on patient communication about sexual health in gynecologic cancer and other patient health outcomes. Approximately 30 women with a diagnosis of gynecologic cancer will be randomized to either participate in either the Starting the Conversation (STC) condition, consisting of an educational video, workbook, and list of resources on sexual and menopausal health, or to a control condition offering the resource guide only. Patients will be asked to review intervention materials prior to their next clinic visit with their gynecologic cancer provider. The investigators will examine effects of the interventions on patients' beliefs about communication about sexual health and on patients' communication about sexual health during clinic visits with their providers. Secondarily, the investigators will examine effects of the interventions on sexual outcomes and other health outcomes, including psychological well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 9, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 4, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2022

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

September 25, 2024

Completed
Last Updated

September 25, 2024

Status Verified

September 1, 2024

Enrollment Period

6 months

First QC Date

April 29, 2022

Results QC Date

May 14, 2024

Last Update Submit

September 19, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Feasibility - Enrollment

    Study enrollment, defined as the number of participants randomized out of the number of eligible patients approached for participation

    Baseline

  • Feasibility - Retention

    Number of enrolled participants that complete the final study survey.

    2 months

  • Feasibility - Intervention Completion

    Number of participants randomized to receive the Starting the Conversation intervention who report having engaged at least somewhat with the video and/or accompanying workbook.

    2 weeks

  • Acceptability

    The number of participants randomized to receive the Starting the Conversation intervention who endorse at least 6 of 8 core components of the Starting the Conversation Intervention (defined as satisfaction with the intervention, informativeness of the intervention, helpfulness of the intervention, relevance of the intervention, ease of participation, approval of the intervention format, likelihood of recommending the intervention to others, and perceived importance of the intervention for people with gynecologic cancer).

    2 weeks

Secondary Outcomes (9)

  • Self-Efficacy - Post-Intervention

    2 weeks

  • Self-Efficacy - 2-Month Follow Up

    2 months

  • Clinical Communication - Discussion of Sexual Health

    2 weeks

  • Clinical Communication - Raising Topic of Sexual Health

    2 weeks

  • Clinical Communication - Asking a Question About Sexual Health

    2 weeks

  • +4 more secondary outcomes

Study Arms (2)

Starting the Conversation

EXPERIMENTAL

Participants are asked to watch an educational video along with an accompanying workbook (called "Starting the Conversation"). Participants are also asked to review a list of resources about sexual and menopausal health relevant to gynecologic cancer.

Behavioral: Starting the ConversationBehavioral: Sexual and Menopausal Health Resources Only

Sexual and Menopausal Health Resources Only

ACTIVE COMPARATOR

Participants are given the list of resources about sexual and menopausal health only.

Behavioral: Sexual and Menopausal Health Resources Only

Interventions

The Starting the Conversation intervention consists of a brief educational video and accompanying workbook with activities to help prepare patients to discuss sexual and menopausal types of health concerns effectively with gynecologic cancer providers, including prioritizing concerns, tips for effective communication, communication practice, and self-feedback. In addition, participants receive a list of sexual and menopausal resources.

Starting the Conversation

A list of resources on sexual/menopausal health both within and outside the institution, including websites.

Sexual and Menopausal Health Resources OnlyStarting the Conversation

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of any stage (I-IV) gynecologic cancer (uterine, ovarian, cervical, vaginal/vulvar, fallopian tube, peritoneal)
  • Receiving any treatment for gynecologic cancer or have completed acute treatment \< 10 years ago
  • Attending clinic visits in the course of follow-up care (i.e., not an initial consult visit)

You may not qualify if:

  • Not able to speak English
  • Eastern Cooperative Oncology Group (ECOG) Performance status score \> 2
  • Overt cognitive dysfunction or psychiatric disturbance or severe mental illness (e.g., dementia, suicidal behavior, or psychosis), as observed or judged by the researcher or referring source.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fox Chase Cancer Center

Philadelphia, Pennsylvania, 19111, United States

Location

MeSH Terms

Interventions

Sex

Intervention Hierarchy (Ancestors)

Reproductive Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Results Point of Contact

Title
Dr. Jennifer Reese, Associate Professor
Organization
Fox Chase Cancer Center

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2022

First Posted

May 4, 2022

Study Start

February 9, 2022

Primary Completion

August 22, 2022

Study Completion

August 22, 2022

Last Updated

September 25, 2024

Results First Posted

September 25, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations